What’s happening – Covid19-ARDs trial?
Early doors there was mention that there was to be recruitment of 300 patients from 30 sites America wide and a rapid mobilisation with expectancy of early enrolment given the dire situation. This has been moderated to more than 20 centres to the latest mention of more than 17 centres.
What; there is the sudden realisation that there are no/insufficient takers for this trial to complete the required 300 enrolment? That to reach the 300 target there is a need to reach out and engage with other hospitals (in Australia) that may be more amenable/interested? Is the 300 patient enrolment a necessary requirement before the release of a preliminary trial report?
Is NIH administering/funding the Australian component of the trial? or has NIH just failed to deliver/or has dragged its heels regarding recruitment? I’m getting the feeling that this blinded trial might be more a case of the blind leading the blind, but I DON’T KNOW, -requires a Pauline Hansen.
- Forums
- ASX - By Stock
- Ann: Ethics Approval to Treat COVID-19 Patients in Australia
What’s happening – Covid19-ARDs trial?Early doors there was...
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 274918 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 974 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 103162 | 0.970 |
5 | 34741 | 0.965 |
11 | 125566 | 0.960 |
1 | 500 | 0.955 |
22 | 165429 | 0.950 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 974 | 1 |
0.990 | 10204 | 1 |
1.000 | 14000 | 1 |
1.010 | 2877 | 1 |
1.015 | 60000 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |